Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Get an overview of common budgeting traps and why they happen. This intro explains prevention tips to keep your budget on track.
10,784 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Allstate beats on underwriting and returns capital, while Progressive shows growth but a steadier combined ratio. The...
Five dividend-paying giants have sat on Goldman Sachs' Conviction List the longest, underscoring steady income as mar...
A new Samsung-deepseek partnership is stirring the AI hardware scene. This guide breaks down what DeepSeek could mean...
RE/MAX elevates Chris Lim to president while bringing in two new global sales leaders to drive growth across its affi...
Two popular healthcare ETFs—IHE and IBB—offer very different routes to exposure: established pharma vs biotech innova...
Lawmakers are shifting from hearings to formal regulatory pressure, focusing on how overseas players influence crypto...
Cineverse is navigating the shifting streaming landscape as it reports 2026 earnings. This guide explains what the nu...
Unlock the signals behind American Water Works earnings calls. Learn how to read the transcript, spot growth drivers,...
Could Bloom Energy ride AI demand like Nvidia did? This comprehensive guide weighs the parallels, the risks, and prac...
A rising institutional move shines a light on how large managers deploy capital in broad market ETFs. This piece brea...
Two physical silver ETFs track the LBMA price, but a fee gap and liquidity differences drive the decision on which to...